Chicago: The ASCO 2014 conference is in full swing as it enters day 3. We’re continuing our coverage of the meeting with our daily live blog where we post regular updates of data that catches our interest or quick notes from sessions we’ve been to.
What have been the highlights so far – well the AZD9291 vs. CO-1686 debate is keeping the analysts busy. I interviewed Dr Pasi Jänne yesterday about the AZD9291 data and will be talking with Dr Lecia Sequist later today to talk about CO-1686. Meetings such as ASCO do afford the opportunity to talk to thought leaders.
What’s on the agenda this morning?
Subscribers can login to read where we’ll be at and what we will be covering.
Good morning from Chicago and the annual meeting of the American Society of Clinical Oncology (ASCO) where we are continuing our coverage of the meeting with a live blog from day 2 of the meeting.
As the day progresses we’ll be adding in tweets we want to share, short comments on sessions we attend (blog posts will follow later), and time-permitting excerpts of interviews. It’s an experiment, so bear with us, we hope it works and doesn’t distract too much from time spent gathering data and talking to people.
Subscribers can log to learn more insights from the conference.
Chicago: Welcome to ASCO 2014 (#ASCO14), and this year’s annual meeting of the American Society of Clinical Oncology (ASCO) and the world’s largest cancer conference.
It’s the Super Bowl of cancer conferences – the meeting you not only have to be at if you’re in the field, but where you want to have your data presented. The press room is truly multinational.
The weather I have to say is glorious in Chicago, it’s probably the best time of year to visit, but as anyone who has ever been to ASCO knows, it’s an all consuming meeting and you never have any chance to visit the sights, although the travel department has kindly provided a room with a view.
This year we’ll be writing daily blog posts that provide rolling coverage – as and when the opportunity presents – we’ll be updating the post with news, commentary, and the occasional picture or clip from an interview.
Today, despite being primarily a travel day, we made it to a couple of the poster highlights sessions.
Sadly, with flights, hotels and bar bills to pay, the ASCO coverage is for subscribers only. The first of our live blogs begins below. It will probably kill us to do this, but here goes…..we’re kicking off with some commentary on the poster highlights sessions.
Subscribers can log-in to read more.